Results 171 to 180 of about 267,025 (304)

Primary Care-Based Estimates of Influenza Vaccine Effectiveness in Hungary, 2024/25. [PDF]

Vaccines (Basel)
Túri G, Velkey V, Juhász KM, Krisztalovics K, Ferenczi A, Luca C, Bilics E, Kristóf K, Oroszi B.   +8 more
europepmc   +1 more source

All roads lead to infection: A mechanistic model to assess transmission routes of brucellosis in a wild ungulate population

Functional Ecology, EarlyView.
Read the free Plain Language Summary for this article on the Journal blog. Abstract Wildlife and domestic populations frequently share diseases with a potential for cross‐species transmission, posing significant threats to animal and human health, economy and biodiversity conservation.
Rémi Fay, Sébastien Lambert, Anne Thébault, Pascal Marchand, Ariane Payne, Elodie Petit, Carole Toïgo, Emmanuelle Gilot‐Fromont   +7 more
wiley   +1 more source

Safety profile of India's influenza vaccine in a large-scale corporate vaccination drive. [PDF]

Hum Vaccin Immunother
Khatuja N, Aggarwal R, Dutta T, Mahajan M.   +3 more
europepmc   +1 more source

Influenza Vaccine [PDF]

Public Health Reports (1896-1970), 1958
openaire   +2 more sources

Crisis micro‐learning: A framework for understanding the micro‐flow of policy learning and Australia's COVID‐19 response

Australian Journal of Public Administration, EarlyView.
Abstract COVID‐19 has intensified interest in crisis policy learning, yet the micro‐level interactions among political, bureaucratic, and expert actors remain underexplored. We conceptualise an ideal‐type framework for the micro‐flow of crisis learning, an ordinarily epistemic and context‐specific process of individual‐level interactions, where lessons
Neil Mortimer, Nicholas Bromfield
wiley   +1 more source

Statins, Influenza Vaccination and Influenza [PDF]

Journal of Infectious Diseases, 2016
openaire   +2 more sources

Update on Non‐Biological and RNA‐Based Therapeutics in Chronic Inflammatory Diseases: Precision Medicine Through Small Molecules: An EAACI Position Paper

Allergy, EarlyView.
ABSTRACT In the last decades, critical advancements in research technology and knowledge on disease mechanisms steered therapeutic approaches for chronic inflammatory diseases towards unprecedented target specificity. For allergic and chronic lung diseases, biologic drugs pioneered this goal, acquiring on the way—through the clinical use of monoclonal ...
F. Roth‐Walter, I. M. Adcock, C. Benito‐Villalvilla, R. Bianchini, L. Bjermer, G. Caramori, L. Cari, K. F. Chung, Z. Diamant, I. Eguiluz‐Gracia, E. F. Knol, M. Jesenak, F. Levi‐Schaffer, G. Nocentini, L. O'Mahony, O. Palomares, F. Redegeld, M. Sokolowska, B. Van Esch, M. Zurlo, C. Stellato   +20 more
wiley   +1 more source

Influenza vaccine Hesitancy in older adults in China: A latent profile analysis. [PDF]

Hum Vaccin Immunother
Chen X, Xia S, Zhu Z, Hui Z, Wu J, Sun C, Zhou C, Ceng L.   +7 more
europepmc   +1 more source

Fel d 1‐Expressing Plant‐Derived Bioparticle: A Novel Treatment for Cat Allergy

Allergy, EarlyView.
This study investigates the allergenicity and immunogenicity profile of a novel plant‐derived Fel d 1 bioparticle (eBP). Fel d 1 eBP promotes immune tolerance by redirecting allergic Th2 responses toward Th1 and IL‐10–producing regulatory pathways, including Bregs.
Janice A. Layhadi, Liliana Cifuentes Gutierrez, Sean T. Keane, William Fulton, Nichell A. Samson, Lily Y. D. Wu, Paulina Filipaviciute, Prista Hikmawati, Oleksandra Fedina, Ana Jimenez‐Gil, Stephen R. Durham, Guy Scadding, Guy Tropper, Louis‐Philippe Vézina, Patrick Colin, Ronald van Ree, Mohamed H. Shamji   +16 more
wiley   +1 more source

Blinatumomab limits humoral antibody response despite boosting the influenza vaccine schedule in children with B-ALL. [PDF]

Blood Adv
Chiu SK, Furlong E, Fox A, McKinnon EJ, Ovando SS, McLean-Tooke A, Oommen J, Yeoh DK, Cheung LC, Gottardo NG, Kotecha RS.   +10 more
europepmc   +1 more source